Insider filing · ANIP
Muthusamy Shanmugam
HEAD OF R&D, COO-NOVITIUM OPS
profile →
ANI Pharmaceuticals, Inc.
ANIP · Healthcare · 50 filings in 24 months
ticker →
Muthusamy Shanmugam sold $9.0M of ANI Pharmaceuticals (ANIP)
Executed Aug 20 2025, disclosed Aug 22 2025, 2 days later.
Value, as filed
$9.0M
100,000 sh across 2 lots
Executed
Aug 20 2025
the trade date, as filed
Disclosed
Aug 22 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MSMuthusamy Shanmugam (HEAD OF R&D, COO-NOVITIUM OPS) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $9.0M of ANIP (100,000 sh across 2 lots, as filed), executed Aug 20 2025.
The name
ANIPHealthcare · ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Muthusamy Shanmugam in ANIP
ANIPSALE
ANI Pharmaceuticals, Inc.
$8.8M100,000 sh across 2 lots
Exec Aug 14 2025
Filed Aug 18 2025 · 5:30 PM ET